关注
Claudia Cerella
Claudia Cerella
Laboratoire de Biologie Moléculaire et Cellulaire du Cancer (LBMCC), Luxembourg
在 lbmcc.lu 的电子邮件经过验证
标题
引用次数
年份
Antileukemic potential of methylated indolequinone MAC681 through immunogenic necroptosis and PARP1 degradation
B Orlikova-Boyer, A Lorant, SR Gajulapalli, C Cerella, M Schnekenburger, ...
Biomarker Research 12 (1), 47, 2024
2024
ATP1A1/BCL2L1 predicts the response of myelomonocytic and monocytic acute myeloid leukemia to cardiac glycosides
C Cerella, SR Gajulapalli, A Lorant, D Gerard, F Muller, Y Lee, KR Kim, ...
Leukemia 38 (1), 67-81, 2024
2024
Enhancing personalized immune checkpoint therapy by immune archetyping and pharmacological targeting
C Cerella, M Dicato, M Diederich
Pharmacological Research, 106914, 2023
22023
Marine polyether phycotoxin palytoxin induces apoptotic cell death via Mcl-1 and Bcl-2 downregulation
J Kim, S Ji, JY Lee, J Lorquin, B Orlikova-Boyer, C Cerella, A Mazumder, ...
Marine drugs 21 (4), 233, 2023
12023
Next-Generation Cancer Therapies Based on a (R) evolution of the Biomarker Landscape
C Cerella, A Lorant, K Aquilano, M Diederich
Frontiers in Pharmacology 13, 861424, 2022
2022
Phytochemical Screening and Antioxidant and Cytotoxic Effects of Acacia macrostachya
HT Ganamé, Y Karanga, I Tapsoba, M Dicato, MF Diederich, C Cerella, ...
Plants 10 (7), 1353, 2021
82021
Anti-leukemic properties of aplysinopsin derivative ee-84 alone and combined to bh3 mimetic a-1210477
S Song, S Kim, ER El-Sawy, C Cerella, B Orlikova-Boyer, G Kirsch, ...
Marine drugs 19 (6), 285, 2021
102021
BH3 mimetics in AML therapy: death and beyond?
C Cerella, M Dicato, M Diederich
Trends in Pharmacological Sciences 41 (11), 793-814, 2020
222020
Tetrahydrobenzimidazole TMQ0153 triggers apoptosis, autophagy and necroptosis crosstalk in chronic myeloid leukemia
S Song, JY Lee, L Ermolenko, A Mazumder, S Ji, H Ryu, HJ Kim, DW Kim, ...
Cell death & disease 11 (2), 109, 2020
302020
Petromurin C induces protective autophagy and apoptosis in FLT3-ITD-positive AML: synergy with gilteritinib
YN Ha, S Song, B Orlikova-Boyer, C Cerella, C Christov, A Kijjoa, ...
Marine drugs 18 (1), 57, 2020
122020
Les polysulfides anticancéreux induisent l’apoptose des cellules issues de cancers colorectaux par arrêt de la division cellulaire et du flux autophagique
EY Efe, A Mazumder, JY Lee, A Gaigneaux, F Radogna, MJ Nassim, ...
Morphologie 103 (342), 69-70, 2019
2019
Hydroquinone-derivatives induce cell death in chronic Myelogenous leukemia
S Song, C Cerella, B Orlikova-Boyer, A Al-Mourabit, M Diederich
Proceedings 11 (1), 28, 2019
12019
Targeted Anticancer Strategies with Garlic Derivatives
C Cerella, EY Efe, M Dicato, M Diederich
Proceedings 11 (1), 29, 2019
12019
Hydroxycoumarin OT-55 kills CML cells alone or in synergy with imatinib or Synribo: Involvement of ER stress and DAMP release
A Mazumder, JY Lee, O Talhi, C Cerella, S Chateauvieux, A Gaigneaux, ...
Cancer letters 438, 197-218, 2018
332018
Natural scaffolds in anticancer therapy and precision medicine
A Mazumder, C Cerella, M Diederich
Biotechnology advances 36 (6), 1563-1585, 2018
422018
PO-064 Tubulin-binding anti-cancer polysulfides induce cell death via mitotic arrest and autophagic interference in colon cancer
E Yagdi, A Mazumder, JY Lee, A Gaigneaux, F Radogna, M Dicato, ...
ESMO Open 3, A46, 2018
2018
Biotinylation enhances the anticancer effects of 15d‑PGJ2 against breast cancer cells
C Colin, M Meyer, C Cerella, A Kleinclauss, G Monard, M Boisbrun, ...
International Journal of Oncology 52 (6), 1991-2000, 2018
62018
Cardiac glycoside glucoevatromonoside induces cancer type-specific cell death
NFZ Schneider, C Cerella, JY Lee, A Mazumder, KR Kim, A De Carvalho, ...
Frontiers in pharmacology 9, 70, 2018
392018
Cytostatic hydroxycoumarin OT52 induces ER/Golgi stress and STAT3 inhibition triggering non-canonical cell death and synergy with BH3 mimetics in lung cancer
JY Lee, O Talhi, D Jang, C Cerella, A Gaigneaux, KW Kim, JW Lee, ...
Cancer letters 416, 94-108, 2018
392018
The dialkyl resorcinol stemphol disrupts calcium homeostasis to trigger programmed immunogenic necrosis in cancer
S Ji, JY Lee, J Schrör, A Mazumder, DM Jang, S Chateauvieux, ...
Cancer letters 416, 109-123, 2018
222018
系统目前无法执行此操作,请稍后再试。
文章 1–20